Back to Search Start Over

Central Nervous System Lymphoma Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Novartis, Incyte, AstraZeneca, Roche, Cellectar Biosciences

Source :
M2 Presswire. October 10, 2023
Publication Year :
2023

Abstract

M2 PRESSWIRE-October 10, 2023-: Central Nervous System Lymphoma Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Novartis, Incyte, AstraZeneca, Roche, Cellectar Biosciences (C)1994-2023 [...]

Subjects

Subjects :
Novartis AG -- Forecasts and trends
Incyte Corp. -- Forecasts and trends
AstraZeneca PLC -- Forecasts and trends
Business -- Research
Antineoplastic agents -- Forecasts and trends
Biotechnology industry -- Forecasts and trends
Non-Hodgkin's lymphomas -- Drug therapy
Drug approval -- Forecasts and trends
Epidemiology -- Forecasts and trends
Pharmaceutical industry -- Forecasts and trends
Central nervous system -- Forecasts and trends
Antimitotic agents -- Forecasts and trends
Market trend/market analysis
Business
Business, international

Details

Language :
English
Database :
Gale General OneFile
Journal :
M2 Presswire
Publication Type :
News
Accession number :
edsgcl.768304611

Tools

Authors Abstract Subjects Details